Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
An approachable overview comparing passive retirement investing using index funds versus ETFs, highlighting costs, flexibility, and long-term potential.
25,186 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Arm Holdings has ridden a scorching AI-fueled rally in 2026, but today’s roughly 10% slide raises questions about mom...
Nvidia is fueling a bold thesis for H2 2026 as AI infrastructure demand climbs. With data-center momentum and locked-...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Bitcoin slipped below the $59,000 level for the first time in almost two years, intensifying a risk-off mood as Micro...
FuelCell Energy leads a sell-off in fuel-cell stocks as investors lock in gains after a sharp rally, while Bloom Ener...
XRP faces renewed selling pressure as it tests critical support around $1.00, with bears signaling caution across bot...
The BIS warns that stablecoins becoming central bank policy questions are moving from crypto markets into sovereign d...
As India intensifies crypto oversight, the local premium for USDT widens to 8.5%, forcing rupee buyers into costlier ...
As AI accelerates, tech’s demand uninterrupted power is forcing investors to rethink NextEra Energy’s renewables-led ...
Enphase Energy and SolarEdge surged roughly 8% in morning trading as investors chase AI data-center power plays, exte...
U.S. regulators move to clear the way for civilian supersonic flights over the continental United States, setting noi...